Transversal Categories Archives -

The way pharmaceutical companies manage data carries inherent risks, as exemplified by the constant scandals about data breaches.

How decentralised storage networks can change the game for the pharmaceutical industry

https://pharmaphorum.com/views-and-analysis/how-decentralised-storage-networks-can-change-the-game-for-pharma/

Healthcare/ Patients/ Transversal Categories/ Views & Analysis/ Views and analysis

The end-of-life care conundrum

Ben Hargreaves chemotherapy, end of life care, healthcare, immunotherapy, patients, quality of life 0 Comment

Research advises against aggressive cancer treatment at the end-of-life stages of the disease. At the same time, the

The end-of-life care conundrum

https://pharmaphorum.com/views-and-analysis/the-end-of-life-care-conundrum/

Healthcare/ Patients/ Sustainability/ Transversal Categories/ Views & Analysis/ Views and analysis

Bring point of care testing to the community for a preventative, cost effective, Net Zero NHS

mike.hammerton@pharmaphorum.com carbon emissions, diagnostic services, net zero, NHS, Patient Care, point of care, testing 0 Comment

The vast majority of GPs are persuaded of the benefits of moving diagnostic services from the hospital to

Bring point of care testing to the community for a preventative, cost effective, Net Zero NHS

https://pharmaphorum.com/views-and-analysis/bring-point-of-care-testing-to-the-community-for-a-preventative-cost-effective-net-zero-nhs/

Digital/ Healthcare/ Insights/ Insights/ Insights/ Insights/ Market Access/ Oncology/ Patients/ Pharma Market Access/ Podcast/ R&D/ Sales and Marketing/ Transversal Categories/ Video/ Views and analysis

A few of 2022’s biggest pharma trends – the pharmaphorum podcast

Jonah Comstock 2023 trends, AI, clinical trials, covid19, digital health, machine learning, Oncology, patient centricity, pharma trends, pharmaphorum, precision medicine 0 Comment

As we close out the year, pharmaphorum’s editorial team sat down together for a roundtable discussion of some

A few of 2022’s biggest pharma trends – the pharmaphorum podcast

https://pharmaphorum.com/podcast/a-few-of-2022s-biggest-pharma-trends/

Market Access/ Pharma Market Access/ Sales and Marketing/ Transversal Categories/ Views & Analysis/ Views & Analysis/ Views and analysis

Pharma manufacturing can digitalise its way round the next crisis

mike.hammerton@pharmaphorum.com cost, digitalisation, efficiency, Innovation, manufacturing, medicines, modelling, pharma, pharma manufacturing, workflow 0 Comment

The turbulence of the last three years can make it seem as though pharma manufacturers have been operating

Pharma manufacturing can digitalise its way round the next crisis

https://pharmaphorum.com/views-and-analysis/pharma-manufacturing-can-digitalise-its-way-round-the-next-crisis/

Digital/ Healthcare/ Transversal Categories/ Views & Analysis/ Views and analysis

How medical device sales teams can embrace digital transformation

mike.hammerton@pharmaphorum.com AR, asynchronous communication, automation, digital, HCPs, healthcare, medical device, sales, VR 0 Comment

Selling amid a global pandemic has changed the face of sales forever. This is nowhere more pronounced than

How medical device sales teams can embrace digital transformation

https://pharmaphorum.com/views-and-analysis/how-medical-device-sales-teams-can-embrace-digital-transformation/

M&A/ Sales and Marketing/ Startups/ Transversal Categories/ Views & Analysis/ Views & Analysis/ Views and analysis

How to get acquisition ready – a seller’s guide to merger and acquisition in pharma

mike.hammerton@pharmaphorum.com acquisition, compliance, due diligence, M&A, merger, negotiations, pharma, Regulations, startups, strategy 0 Comment

This year, the predicted flurry of merger and acquisition (M&A) activity might not have materialised. However, as we

How to get acquisition ready – a seller’s guide to merger and acquisition in pharma

https://pharmaphorum.com/views-and-analysis/how-to-get-acquisition-ready-a-sellers-guide-to-merger-and-acquisition-in-pharma/

Sales and Marketing/ Sales and Marketing/ Transversal Categories/ Views & Analysis/ Views and analysis

7 commercial, sales, and marketing predictions for 2023

mike.hammerton@pharmaphorum.com 2023 predictions, autmation, Clinical, commercial, data access, digital, HCPs, marketing, Medical, MLR, omnichannel, patient centricity 0 Comment

In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and

7 commercial, sales, and marketing predictions for 2023

https://pharmaphorum.com/views-and-analysis/7-commercial-sales-and-marketing-predictions-for-2023/

Cancer/ Events/ Oncology/ Transversal Categories/ UK & Europe/ Views & Analysis/ Views and analysis/ World Cancer Series

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part iv)

Nicole Raleigh cancer, cancer control, data, diagnostics, equity, Europe, Innovation, patient engagement, The Economist, The Economist’s 8th Annual World Cancer Series congress, World Cancer Series 0 Comment

To conclude pharmaphorum’s look back at day one of The Economist’s 8th Annual World Cancer Series congress in

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part iv)

https://pharmaphorum.com/oncology/economist-impact-world-cancer-series-pharmaphorum-in-attendance-day-one-part-iv/

Trending

Transversal Categories

Login